Hyro Secures $50 Million in Series B Funding to Expand Conversational AI in Healthcare and Beyond

Hyro, a leading provider of conversational AI solutions, has secured an extension of its Series B funding round, bringing the total amount raised to $35 million. This latest investment was led by Healthier Capital, with participation from existing investors Macquarie Capital, Liberty Mutual Strategic Ventures, and Black Opal Ventures. The funding round now totals $50 million, marking a significant milestone for the company.

Hyro’s conversational AI platform is designed to streamline patient interactions and improve operational efficiencies in healthcare and other regulated industries. The company’s technology features both conversational and generative AI capabilities, enabling large organizations to automate digital services and enhance patient engagement.

The new funding will be used to expand Hyro’s healthcare footprint and introduce tools for the payer and pharmaceutical markets. The company plans to enhance its outbound calling offering, focusing on appointment no-shows and encouraging patients to switch from reactive to proactive care. Additionally, Hyro will further develop its analytics suite to provide deeper insights into patient interactions.

Israel Krush, CEO and co-founder of Hyro, expressed his enthusiasm for the investment, stating, “Healthier Capital’s investment is a testament to the trust we’ve established in our ability to deliver stellar outcomes. We are thrilled to have the Healthier Capital team in our corner.”

Amir Dan Rubin, founder of Healthier Capital and former CEO of Amazon’s One Medical, executive vice president at Optum/UnitedHealth Group, and CEO at Stanford Health Care, will join Hyro’s board as part of the transaction. Rubin’s extensive experience in healthcare innovation will be invaluable to Hyro as it continues to grow and expand its offerings.

Hyro has experienced significant growth since its launch in 2020, with annual recurring revenue increasing by over 100% year over year. The company has delivered conversational experiences to over 30 million enterprise consumers, resulting in tens of millions of dollars in operational savings.

The investment from Healthier Capital follows a previous Series B funding round led by Macquarie Capital in May 2023, which raised $20 million. Hyro has also partnered with patient communication platform Artera to launch Artera Care Assist, an AI-powered virtual assistant powered by Hyro that can be embedded into a health provider’s website to answer common patient questions.

With this latest funding, Hyro is poised to continue its expansion and innovation in the conversational AI space, particularly in healthcare. The company’s commitment to delivering high-quality, patient-centric solutions has earned it a reputation as a leader in the industry, and this investment will enable it to further solidify its position.

Hyro’s no-code platform for AI-powered call center, web, and mobile solutions has been instrumental in its success, allowing large organizations to automate digital services and improve operational efficiencies. The company’s focus on explainability around AI outputs, through its GPT-powered assistant Spot, has also been a key differentiator in the market.

As the demand for conversational AI solutions continues to grow, Hyro is well-positioned to capitalize on this trend. With its strong leadership team, innovative technology, and significant funding, the company is set to make a lasting impact in the healthcare and technology industries.